Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 millionCash and cash ...
DCT approaches in Japan typically involve partnerships among multiple satellite hospitals. Three main models aim to boost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback